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In a recently published article Grinberg 
et al. (2014) analysed gene expression altera-
tions induced by 148 compounds in cultivat-
ed human hepatocytes. The high number of 
analyzed compounds allowed a comprehen-
sive study of the key features of chemically 
up or downregulated genes. The authors re-
vealed four key features that are of high in-
terest for further studies in this field of toxi-
cogenomics. First, a stereotypical stress re-
sponse has been observed. When hepatocytes 
are exposed at close to cytotoxic concentra-
tions, they respond with a very similar pat-
tern of deregulated genes for different com-
pounds. This stereotypical response can be 
differentiated from more specific gene ex-
pressions alterations that are induced only by 
individual or small numbers of compounds. 
Second, approximately 20 % of the chemi-
cally altered genes overlap with genes whose 
expression is deregulated in human liver dis-
ease, such as steatosis or fibrosis. Third, the 
numbers of biological functions of the chem-
ically altered genes are limited. Although 
more than 2000 genes are up or downregu-
lated they mostly can be assigned to the cat-
egories xenobiotic, energy and lipid metabo-
lism, inflammation and immune response, 
protein modification, cytoskeletal organisa-
tion, stress response and DNA repair. Finally 
Grinberg et al. (2014) describe a set of ‘un-
stable baseline genes’, whose expression is 
already altered by the hepatocyte isolation 
and cultivation process. Therefore, these 
genes should be interpreted with caution. 
Currently, identification of biomarkers of 
toxicity is an intensively studied field of re-
search (Kolisetty et al., 2013; Song et al., 
2013; Black and Read, 2013; Pavanello and 
Lotti, 2012; Kim et al., 2012; Park et al., 
2011; Delaney et al., 2005; Angerer et al., 
1998; Usuda et al., 1998). Within this field, 
gene expression analyses are particularly 
popular, because of the possibility of ge-
nome-wide analyses (Van Kesteren et al., 
2013; Jennings et al., 2012; Drasdo et al., 
2014; Hrach et al., 2011; Guo et al., 2008; 
Page et al., 2007; Hammad et al., 2013). For 
example, identification of compounds induc-
ing developmental neurotoxicity has been 
made possible based on gene expression 
analysis of differentiating stem cells (Weng 
et al., 2014; Zimmer et al., 2014; Waldmann 
et al. 2014; Leist et al., 2013; Krug et al., 
2013; Powers et al., 2013; Bolt, 2013). 
Much research has been invested into the 
development and optimization of in vitro 
systems (Frey et al., 2014; Theocharis et al., 
1994; Godoy and Bolt, 2012; Schug et al., 
2013; Godoy et al., 2009). Toxicogenomics 
will be particularly helpful to further develop 
these systems and define to which degree 
they correctly predict expression responses 
in vivo. 
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Although a high number of studies have 
been published in the field of toxicoge-
nomics, they usually only comprise a rela-
tively small number of compounds. The 
study of Grinberg et al. (2014) is the first 
that includes genome-wide expression data 
of more than 100 compounds and therefore 
is able to derive general principles how the 
universe of chemically altered gene is orga-
nized. The study together with the supple-
mental toxicotranscriptomics directory offers 
a valuable source for an optimal choice of 
candidate genes for biomarker evaluation 
studies. 
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